When you buy through links on our articles, Future and its syndication partners may earn a commission.Credit: Amazon MGM StudiosMelania,...
Highlights
First Business Financial Services logo Strong 2025 results: Management reported high-quality growth with pre-tax, pre-provision earnings up nearly 15% year-over-year,...
MIAMI, Oct. 29, 2025 (GLOBE NEWSWIRE) -- OPKO Health, Inc. (NASDAQ: OPK) (OPKO) reports business highlights and financial results for...
Fulcrum Therapeutics, Inc. ― Announced results from the 12 mg dose cohort (n=16) of the Phase 1b PIONEER trial of...
- Dosing is underway in the Phase 3 CYB003 PARADIGM program which comprises two 12-week randomized, double-blind, placebo-controlled studies (APPROACH™...
-- iMMagine-1 data accepted for Oral Presentation at EHA -- -- iMMagine-3 study updated to include MRD negativity as a...
